• A+ Standard
  • A+ Larger
  • A+ Extra Large

  • Standard Contrast
  • Low Contrast
  • High Contrast

Pharmacological inhibition of PRMT5 demonstrates broad efficacy in multiple preclinical models of autoimmunity and inflammation by suppressing Th1, Th17 and TNF-mediated inflammatory responses

Neha Bhagwat, Kumar Penmetsa, Matt Devalaraja, Suzana Marusic, Shozo Ohtsuki, Cornelia M. Weyand, Peggy Scherle, Kris Vaddi

Poster presented at

ACR Convergence 2023, November 10-15, 2023, San Diego, CA, USA

This is an electronic reproduction of a poster presented at ACR Convergence 2023, November 10-15, 2023, San Diego, CA, USA. All copyrights remain those of the copyright holder. This page will not be available after December 15, 2023.